Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.
about
Down-regulated CFTR During Aging Contributes to Benign Prostatic HyperplasiaRole of prostaglandin E receptor subtypes EP2 and EP4 in autocrine and paracrine functions of vascular endothelial growth factor in the inner ear.Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancerPTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.Aspirin and other NSAIDs as chemoprevention agents in melanomaEicosanoids and cancerMicroarray Analysis of Gene Expression Reveals that Cyclo-oxygenase-2 Gene Therapy Up-regulates Hematopoiesis and Down-regulates Inflammation During Endochondral Bone Fracture Healing.Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities.Inhibiting delta-6 desaturase activity suppresses tumor growth in mice.Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?Animal products, diseases and drugs: a plea for better integration between agricultural sciences, human nutrition and human pharmacologyCyclooxygenase-2 confers growth advantage to syngeneic pancreatic cancer cells.Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy.COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset.A pilot study to investigate if New Zealand men with prostate cancer benefit from a Mediterranean-style diet.Novel link between prostaglandin E2 (PGE2) and cholinergic signaling in lung cancer: The role of c-Jun in PGE2-induced α7 nicotinic acetylcholine receptor expression and tumor cell proliferationmiR-620 promotes tumor radioresistance by targeting 15-hydroxyprostaglandin dehydrogenase (HPGD).Direct Melanoma Cell Contact Induces Stromal Cell Autocrine Prostaglandin E2-EP4 Receptor Signaling That Drives Tumor Growth, Angiogenesis, and Metastasis.A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis.TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway.Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancersProstaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinomaMicrosomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cellsLinking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancerReciprocal cross-talk between Prostaglandin E2 and bone in prostate cancer: a current review.Possible link between cyclooxygenase-inhibiting and antitumor properties of propofol.Role of signaling transduction pathways in development of castration-resistant prostate cancer.RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.Breaking the cycle: the role of omega-3 polyunsaturated fatty acids in inflammation-driven cancers.Prostate Cancer and Aspirin Use: Synopsis of the Proposed Molecular MechanismsIntracellular EP2 prostanoid receptor promotes cancer-related phenotypes in PC3 cells.Novel mechanisms and signaling pathways of esophageal ulcer healing: the role of prostaglandin EP2 receptors, cAMP, and pCREB.Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis.EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer.Effect of a low-fat fish oil diet on proinflammatory eicosanoids and cell-cycle progression score in men undergoing radical prostatectomyHypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.Targeting MRP4 expression by anti-androgen treatment reverses MRP4-mediated docetaxel resistance in castration-resistant prostate cancerBMP-2 induces ATF4 phosphorylation in chondrocytes through a COX-2/PGE2 dependent signaling pathway.Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer.
P2860
Q28575323-D7C983B1-3AA8-4064-9BE2-ECFA7CB2DD00Q30482431-5C8C146B-9129-4D26-AE10-BC46ECC91181Q30497364-C82FFF5E-0CE2-45AD-ABA1-27A1C19CC199Q33723499-BB1C661D-D24D-4A11-8421-8C1B31090F98Q33725012-2C436EAA-0E2E-4278-9F4D-65916357880EQ33966203-74B5A2CC-85A0-4E9B-BACE-9041D4DBFE3DQ34219169-22E1F6A9-901F-4E6A-9815-CF9E2D1D72D2Q34279863-0D93C095-851E-4B3E-8239-B6F9637B1A8FQ34462192-19833974-BC98-429C-A297-670C913DCBB5Q34494513-43FA4677-5592-49D1-AE21-84A8FEEC3456Q34541077-78936B42-43E1-4D3D-96B5-82F6CFBBE2F5Q34802656-82EBA7C0-D24E-4393-A03D-D006C0B37543Q35013758-C33E92CF-4123-4549-96D2-EFCA4560C1C7Q35597212-03F6843B-7313-46FB-AB84-8FF67B6E4ECDQ35818767-C9ADB2D3-8A48-4962-B073-6E507239B899Q35824866-B56E3DEF-5CF9-4DA4-988C-08FA15972A87Q35879417-C9091858-D0D7-4288-BADA-48AA81013A30Q36355984-F7406D79-310E-4883-87FE-075A34700A36Q36444308-DA7DABBE-D28B-4395-B547-E35891A3485FQ36643655-561E8D3A-4703-4CBD-818C-C3CF2B5DD4A4Q36771000-A49344CD-53D8-4DE6-A6E6-16A87251CDE2Q37185881-6645376B-990E-4B30-9C32-5D11FF311D64Q37266333-465EB19F-355A-4D08-A05F-ADB6C3E65808Q37401875-EB39473B-992A-43D0-9679-2D7B9DF91467Q37536891-D2C7EDF6-65BB-4A24-84DC-B56A62E4A76CQ37579078-AC271303-2432-476B-9693-47A46C82DF19Q37879601-D0666DF8-B731-442F-B45E-C846583AEB8BQ37960021-62AE66E8-1A3A-451F-BDDE-4B7D95C7996EQ38161395-998FDA24-4CC5-4CFA-9A71-A63325677A5EQ38237483-195A2D46-256E-4559-8515-D2235A32DBB5Q38854428-C624C2A7-58D3-4F0B-9DB7-98BD630542CEQ38892383-EC92E2C1-CD37-4BFD-9B59-08615704A862Q38971998-ABD2B168-C20A-465F-B701-580A66BF3889Q39004667-608722CE-2A7A-4C49-8CFA-2D22AB0FAC94Q39024826-4927AF6C-B57C-4795-876D-03919D9B172AQ39068984-5C37ACC4-A2A1-41B2-8A02-90DC1D3B99C1Q39144797-9D9F1DF0-593A-44EB-81FF-1EFC21615461Q41143231-31A77D91-5E34-400A-9558-171B79A38518Q41807178-FF6DABB0-8032-41CB-B0D5-EFD57767C6C3Q42045155-49663B67-85B2-4D25-9A0F-AE8A4D61F427
P2860
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.
@ast
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.
@en
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.
@nl
type
label
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.
@ast
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.
@en
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.
@nl
prefLabel
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.
@ast
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.
@en
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.
@nl
P2093
P1433
P1476
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.
@en
P2093
Goutam Chakraborty
Remya Raja
Shalini Jain
Smita Kale
P304
P356
10.1158/0008-5472.CAN-07-6689
P407
P50
P577
2008-10-01T00:00:00Z